Glycated albumin predicts long-term survival in patients undergoing hemodialysis

Chien Lin Lu, Wen Ya Ma, Yuh Feng Lin, Jia Fwu Shyu, Yuan Hung Wang, Yueh Min Liu, Chia Chao Wu, Kuo Cheng Lu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: In patients with advanced renal dysfunction undergoing maintenance hemodialysis, glycated albumin (GA) levels may be more representative of blood glucose levels than hemoglobin A1C levels. The aim of this study was to determine the predictive power of GA levels on long-term survival in hemodialysis patients. Methods: A total of 176 patients with a mean age of 68.2 years were enrolled. The median duration of follow-up was 51.0 months. Receiver-operating characteristic curve analysis was utilized to determine the optimal cutoff value. We examined the cumulative survival rate by Kaplan-Meier estimates and the influence of known survival factors with the multivariate Cox proportional-hazard regression model. Results: In the whole patient group, cumulative survival in the low GA group was better than in the high GA group (p=0.030), with more prominence in those aged <70 years (p=0.029). In subgroup analysis, both diabetic (DM) and non-DM patients with low GA had a better cumulative survival compared with those with high GA. The risk of mortality increased by 3.0% for each 1% increase in serum GA level in all patients undergoing hemodialysis. Conclusions: In addition to serving as a glycemic control marker, GA levels may be useful for evaluating the risk of death in both DM and non-DM patients on hemodialysis.

Original languageEnglish
Pages (from-to)395-402
Number of pages8
JournalInternational Journal of Medical Sciences
Volume13
Issue number5
DOIs
Publication statusPublished - May 10 2016

Fingerprint

Renal Dialysis
Survival
glycosylated serum albumin
Kaplan-Meier Estimate
Proportional Hazards Models
Serum Albumin
ROC Curve
Blood Glucose
Hemoglobins
Survival Rate
Maintenance
Kidney
Mortality

Keywords

  • Glycated albumin
  • Hemodialysis
  • Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Glycated albumin predicts long-term survival in patients undergoing hemodialysis. / Lu, Chien Lin; Ma, Wen Ya; Lin, Yuh Feng; Shyu, Jia Fwu; Wang, Yuan Hung; Liu, Yueh Min; Wu, Chia Chao; Lu, Kuo Cheng.

In: International Journal of Medical Sciences, Vol. 13, No. 5, 10.05.2016, p. 395-402.

Research output: Contribution to journalArticle

Lu, Chien Lin ; Ma, Wen Ya ; Lin, Yuh Feng ; Shyu, Jia Fwu ; Wang, Yuan Hung ; Liu, Yueh Min ; Wu, Chia Chao ; Lu, Kuo Cheng. / Glycated albumin predicts long-term survival in patients undergoing hemodialysis. In: International Journal of Medical Sciences. 2016 ; Vol. 13, No. 5. pp. 395-402.
@article{0b386e4ec7ac4910a22d2b6325dba865,
title = "Glycated albumin predicts long-term survival in patients undergoing hemodialysis",
abstract = "Background: In patients with advanced renal dysfunction undergoing maintenance hemodialysis, glycated albumin (GA) levels may be more representative of blood glucose levels than hemoglobin A1C levels. The aim of this study was to determine the predictive power of GA levels on long-term survival in hemodialysis patients. Methods: A total of 176 patients with a mean age of 68.2 years were enrolled. The median duration of follow-up was 51.0 months. Receiver-operating characteristic curve analysis was utilized to determine the optimal cutoff value. We examined the cumulative survival rate by Kaplan-Meier estimates and the influence of known survival factors with the multivariate Cox proportional-hazard regression model. Results: In the whole patient group, cumulative survival in the low GA group was better than in the high GA group (p=0.030), with more prominence in those aged <70 years (p=0.029). In subgroup analysis, both diabetic (DM) and non-DM patients with low GA had a better cumulative survival compared with those with high GA. The risk of mortality increased by 3.0{\%} for each 1{\%} increase in serum GA level in all patients undergoing hemodialysis. Conclusions: In addition to serving as a glycemic control marker, GA levels may be useful for evaluating the risk of death in both DM and non-DM patients on hemodialysis.",
keywords = "Glycated albumin, Hemodialysis, Mortality",
author = "Lu, {Chien Lin} and Ma, {Wen Ya} and Lin, {Yuh Feng} and Shyu, {Jia Fwu} and Wang, {Yuan Hung} and Liu, {Yueh Min} and Wu, {Chia Chao} and Lu, {Kuo Cheng}",
year = "2016",
month = "5",
day = "10",
doi = "10.7150/ijms.14259",
language = "English",
volume = "13",
pages = "395--402",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "5",

}

TY - JOUR

T1 - Glycated albumin predicts long-term survival in patients undergoing hemodialysis

AU - Lu, Chien Lin

AU - Ma, Wen Ya

AU - Lin, Yuh Feng

AU - Shyu, Jia Fwu

AU - Wang, Yuan Hung

AU - Liu, Yueh Min

AU - Wu, Chia Chao

AU - Lu, Kuo Cheng

PY - 2016/5/10

Y1 - 2016/5/10

N2 - Background: In patients with advanced renal dysfunction undergoing maintenance hemodialysis, glycated albumin (GA) levels may be more representative of blood glucose levels than hemoglobin A1C levels. The aim of this study was to determine the predictive power of GA levels on long-term survival in hemodialysis patients. Methods: A total of 176 patients with a mean age of 68.2 years were enrolled. The median duration of follow-up was 51.0 months. Receiver-operating characteristic curve analysis was utilized to determine the optimal cutoff value. We examined the cumulative survival rate by Kaplan-Meier estimates and the influence of known survival factors with the multivariate Cox proportional-hazard regression model. Results: In the whole patient group, cumulative survival in the low GA group was better than in the high GA group (p=0.030), with more prominence in those aged <70 years (p=0.029). In subgroup analysis, both diabetic (DM) and non-DM patients with low GA had a better cumulative survival compared with those with high GA. The risk of mortality increased by 3.0% for each 1% increase in serum GA level in all patients undergoing hemodialysis. Conclusions: In addition to serving as a glycemic control marker, GA levels may be useful for evaluating the risk of death in both DM and non-DM patients on hemodialysis.

AB - Background: In patients with advanced renal dysfunction undergoing maintenance hemodialysis, glycated albumin (GA) levels may be more representative of blood glucose levels than hemoglobin A1C levels. The aim of this study was to determine the predictive power of GA levels on long-term survival in hemodialysis patients. Methods: A total of 176 patients with a mean age of 68.2 years were enrolled. The median duration of follow-up was 51.0 months. Receiver-operating characteristic curve analysis was utilized to determine the optimal cutoff value. We examined the cumulative survival rate by Kaplan-Meier estimates and the influence of known survival factors with the multivariate Cox proportional-hazard regression model. Results: In the whole patient group, cumulative survival in the low GA group was better than in the high GA group (p=0.030), with more prominence in those aged <70 years (p=0.029). In subgroup analysis, both diabetic (DM) and non-DM patients with low GA had a better cumulative survival compared with those with high GA. The risk of mortality increased by 3.0% for each 1% increase in serum GA level in all patients undergoing hemodialysis. Conclusions: In addition to serving as a glycemic control marker, GA levels may be useful for evaluating the risk of death in both DM and non-DM patients on hemodialysis.

KW - Glycated albumin

KW - Hemodialysis

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=85006826394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006826394&partnerID=8YFLogxK

U2 - 10.7150/ijms.14259

DO - 10.7150/ijms.14259

M3 - Article

AN - SCOPUS:85006826394

VL - 13

SP - 395

EP - 402

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 5

ER -